3 citations · 3 across the 3 of their papers we have counts for
Showing stat.MEShow all
2 papers · 1 filter
stat.ME2022
Analysis and sample size calculation within the responder stratified exponential survival model
Samuel Kilian, Johannes Krisam, Meinhard Kieser
The primary endpoint in oncology is usually overall survival, where differences between therapies may only be observable after many years. To avoid withholding of a promising thera…
stat.ME2020★ 3 cited
Enhancing single-arm phase II trials by inclusion of matched control patients
Johannes Krisam, Dorothea Weber, Richard F. Schlenk +1
When a novel treatment has successfully passed phase I, different options to design subsequent phase II trials are available. One approach is a single-arm trial, comparing the resp…